whereas other studies suggested that genes outside this region also contribute to the DS phenotype.5
The few published cases with DS resulting from a partial trisomy"6 have been very important in establishing a correlation between genotype and phenotype, even though most of these cases have other chromosomal abnormalities, which might contribute to the clinical findings. To define or corroborate the phenotypic map of chromosome 21 further, it is necessary that new cases of partial trisomies are identified and that the chromosomal breakpoints are characterised.
Before the development of fluorescence in situ hybridisation (FISH) techniques in 1986,7 it was only possible to study chromosomal rearrangements by conventional cytogenetics or at best by high resolution cytogenetics. FISH studies now permit the identification of previously undetectable cryptic chromosomal rearrangements, which contribute greatly not only to the correct diagnosis and to adequate genetic counselling but to research studies and the characterisation of the genes interrupted by these rearrangements. With the recent development of genetic maps using highly polymorphic markers89 and the construction of contigs of ordered overlapping YACs and cosmid clones covering the entire long arm of chromosome 21,1011 the use of mapped DNA clones in FISH analysis has been possible and easy. We present here the clinical, cytogenetic, and molecular characterisation of a subject with partial trisomy of chromosome 21 and DS, along with three other members of the family, all of whom carry a balanced translocation between chromosomes 15 and 21. We also performed a prenatal diagnosis for one of the members studied.
Patient and methods
The DS patient was ascertained through his sister, who came to our genetic clinic for counselling. The sister, 29 years old and pregnant, was married to a first cousin on the mother's side and was concerned about the risk to the fetus because of parental consanguinity. She had two brothers, the oldest of whom had been diagnosed with Down syndrome. Family history on the mother's side was unremarkable. No information could be obtained on the fath-er's side as he was adopted as an infant. In order to assess the risk of the fetus having DS, a cytogenetic study was performed on a peripheral blood sample from the mentally retarded brother. Cytogenetic G banding showed an apparently normal karyotype. The patient was then assessed in our genetic clinic and the DS phenotype was verified.
CYTOGENETIC ANALYSIS AND FISH
Metaphase chromosome spreads were prepared from amniocyte and lymphocyte cultures according to standard methods. GTL banding techniques were performed in all cases.
ALU-PCR AMPLIFICATION, LABELLING, AND HYBRIDISATION OF THE PROBES
We generated painting probes from chromosomes 15 and 21 in order to detect the partial trisomy of chromosome 21 resulting from the unbalanced translocation (1 5;2 1). For chromosome 21 we used the hybrid (mousehuman) cell line WAV-1 7, which has chro- One of the difficulties in the construction of a phenotypic map, based on cases of partial trisomy, is that a large proportion of these cases have in addition other chromosomal abnormalities, which may also contribute to the clinical findings. Our patient presents severe mental retardation with absent speech and short stature. However, since these features are associated with a large number of chromosomal aberrations, it is difficult to evaluate the contribution of the chromosome 21 duplication to these. In fact, deletion of 1 5q26-qter, as in our patient, has been associated with both preand postnatal growth retardation, clinodactyly, microcephaly, developmental and speech delay, cafe au lait spots, and discrepancy in leg length.'9 A recent study suggested that growth retardation may be the result of loss or disruption of the insulin-like growth factor receptor I (IGFRI) gene, assigned to 1 5q26. Although short stature in our patient may be partially caused by the partial trisomy 21, the presence of a marked shortening of the extremities, more evident in the arms, is probably the result of partial monosomy of chromosome 15. Application of available molecular cytogenetic tools to study additional cases with similar chromosomal arrangements will help to clarify this issue.
The study presented here highlights several important aspects of the diagnosis of cases of partial trisomy 21. The combination of chromosome painting and FISH using YAC clones as probes permits a rapid characterisation of the chromosomal breakpoint and its correlation with the clinical phenotype. As illustrated in this study, this has important implications for genetic counselling and also allows a fast and reliable prenatal diagnosis to be performed. In addition, this patient contributes to the definition of the phenotypic map of DS which, so far, is based upon a relatively small number of cases with partial trisomy of chromosome 21. With the continued development of molecular cytogenetic tools and the availability of methods and probes for the accurate determination of the chromosomal rearrangements in each case, phenotype/ genotype analysis can be performed with a high degree of accuracy and diagnosis can be performed at the molecular level with a high degree of certainty. 
